Medulloblastoma, a malignant childhood cerebellar tumour, segregates molecularly into
biologically distinct subgroups, suggesting that a personalized approach to therapy would be …

Cancer genomics has revealed many genes and core molecular processes that contribute
to human malignancies, but the genetic and molecular bases of many rare cancers remains …

Long non-coding RNAs are involved in biological processes throughout the cell including
the nucleus, chromatin and cytosol. However, most lncRNAs remain unannotated and …

Recent genomic studies have shed light on the biology and inter-tumoral heterogeneity
underlying pineal parenchymal tumors, in particular pineoblastomas (PBs) and pineal …

Pediatric high-grade glioma (pHGG) is a major contributor to cancer-related death in
children. In vitro and in vivo disease models reflecting the intimate connection between …

Loss of heterozygosity (LOH) at 1p36 occurs in multiple cancers, including neuroblastoma (NBL).
MYCN amplification and 1p36 deletions tightly correlate with markers of tumor …

Pineoblastoma is a rare embryonal tumor of childhood that is conventionally treated with
high-dose craniospinal irradiation (CSI). Multi-dimensional molecular evaluation of …

Methylation profiling has radically transformed our understanding of tumors previously called
central nervous system primitive neuro-ectodermal tumors (CNS-PNET). While this marks a …

The advent of next-generation sequencing for genetic diagnoses of complex developmental
disorders, such as intellectual disability (ID), has facilitated the identification of hundreds of …

Genetic studies have identified many risk loci for autism spectrum disorder (ASD) although
causal factors in the majority of cases are still unknown. Currently, known ASD risk genes are …